Retatrutide 60mg
$100.00
- Significant Weight Reduction: Clinical trials indicate average weight losses of roughly 24% after 48 weeks, rivaling the effects of bariatric surgery.
- Enhanced Metabolism: By activating glucagon receptors, it actively stimulates the body to burn more calories and increases fat oxidation (fat burning).
- Appetite Suppression: Like other GLP-1 and GIP treatments, it regulates hunger by delaying gastric emptying and increasing feelings of fullness.
- Blood Sugar & Insulin Control: It triggers high insulin secretion in response to high blood sugar, leading to drastic HbA1c reductions and improved insulin sensitivity.
- Cardiometabolic Improvements: Early trial data shows improvements in blood pressure, waist circumference, and lipid profiles, with many patients achieving remission of pre-diabetes or fatty liver disease.